- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06693479
Could a Feedback Device Help Manage Work-related Shoulder Disorders?
May 5, 2025 updated by: Jean-Sébastien Roy, Laval University
Could a Feedback Device Help Manage Work-related Shoulder Disorders? - Protocol of a Mixed Methods Pilot Study
Work-related shoulder pain is a common problem with significant socio-economic repercussions.
The impact of these disorders on workers is considerable, particularly in terms of pain, disability and reduced quality of life.
Several occupational factors may explain the onset of these disorders, such as changes in the work environment, physical demands, psychosocial factors specific to the occupational context and the age of workers.
The lack of quantitative measurement tools to assess the physical demands of work over an extended period of time is sorely felt.
Recently, our team developed a wearable feedback device, similar to a watch worn on the arm, which measures shoulder movements and muscle activity, transforming this real-time data into clinical indicators.
These indicators provide immediate feedback to workers, enabling them to better understand the physical demands of their tasks and adapt accordingly.
If this device proves effective in reducing physical demands, it could become a valuable tool for guiding workplace assessments and interventions.
However, this device has not yet been tested on workers with shoulder pain.
For this reason, a two-part pilot study is needed to understand user needs, assess ease of use and the feasibility of implementing the device.
The first component will consist of a pilot clinical trial involving 42 workers suffering from shoulder pain, divided into two groups: one group will use the feedback device for 2 weeks, while the other group will continue to work without intervention.
The second phase will analyze the experience of participants who have used the device.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
The objectives of this pilot study are (a) to evaluate the feasibility of implementing the SWL in the workplace and conducting a large-scale randomized clinical trial (RCT) by assessing recruitment success, intervention adherence, acceptability of the technology, the research team's capacity to refine the SWL, and (b) to explore the SWL capacity to reduce disability, pain, work limitations, and physical work demands while increasing pain self-efficacy among workers with WRSDs.
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jean-Sébastien Roy Jean-Sébastien Roy, PT, PhD
- Phone Number: 46005 418-529-9141
- Email: jean-sebastien.roy@fmed.ulaval.ca
Study Contact Backup
- Name: Philippe Meidinger PT, PhD student
- Email: philippe.meidinger.1@ulaval.ca
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1M 2S8
- Recruiting
- Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS)
-
Contact:
- Jean-Sébastien Roy, Ph.D.
- Phone Number: 46005 418-529-9141
- Email: jean-sebastien.roy@fmed.ulaval.ca
-
Contact:
- Jean Tittley, pht, MSc
- Phone Number: 418-529-0324
- Email: jean.tittley@cirris.ulaval.ca
-
Principal Investigator:
- Philippe Meidinger, pht, Ph.Ds
-
Sub-Investigator:
- Jean Tittley, pht, MSc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult (≧ 18 years) employed full-time (minimum of 30 hours per week).
- Experiencing work-related shoulder disorders (WRSDs), with minimal score of 14 points on the for the abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire (QuickDASH), stemming from a diagnosis of rotator cuff-related shoulder pain (RCRSP), shoulder osteoarthritis (SOA) or rheumatoid arthritis (RA) involving the shoulder.
- Symptoms persisting for more than 6 weeks.
Diagnosis-specific criteria:
- RCRSP: diagnosis requires meeting three positive criteria, including the presence of a painful arc in abduction, a positive Neer sign, Hawkins-Kennedy test, or Jobe Test, pain with resisted humeral external rotation;
- SOA: diagnosis based on clinical findings (e.g., activity-related pain, reduced range of motion particularly external rotation and function, worsening night/rest pain) and radiologic findings (e.g., osteophytes, joint space narrowing, subchondral sclerosis, cyst formations, and humeral head deformities);
- RA involving the shoulder: confirmed diagnosis according to the American College of Rheumatology criteria.
Both SOA and RA diagnoses will be confirmed by a physician.
Exclusion Criteria:
- clinical signs of a massive rotator cuff tear (e.g., pseudoparesis or pseudoparalysis, passive elevation intact but active limited to <90°, without neurologic deficit);
- acute traumatic rotator cuff tears, fractures, adhesive capsulitis (characterized by night pain, pain with sudden or unexpected movements, global loss of active and passive range of motion), or shoulder instability (evidenced by a combination of orthopaedic tests such as apprehension and relocation tests, Jerk, Kim and posterior tests, along with and clinical signs like neuromuscular function impairment, history of instability, lesion mechanisms, worries that their shoulder could dislocate during activities);
- distal neurovascular symptoms (e.g., thoracic outlet syndrome, venous thromboembolism);
- previous shoulder surgery;
- corticosteroid injection administered within the past 3 months;
- symptomatic acromioclavicular joint pathology;
- currently receiving conservative management for their shoulder pain (excluding medication for RA and OA),
- absenteeism from work (unable to work at least 30 hours per week or on sick leave).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Device + Education
Education session at week 2 and feedback from SWL during week 2 and week 3
|
During week 2 and 3 after randomization, the experimental group will undergo the intervention using the SWL, designed to monitor workers' physical work demands.
During this time, the SWL will provide real-time feedback based on parameters set via Ergowatchapp.
A workplace visit by a physiotherapist will be conducted to establish and adjust the feedback thresholds in week 2, after the education intervention.
If necessary, a second remote meeting will take place in week 3 to explain how participants can modify the thresholds themselves.
The initial feedback thresholds will be set based on the physical work demands measured during week 1 and will be adjusted after one week of feedback use.
These thresholds will be collaboratively determined by a physiotherapist and the workers.
Only the experimental group will receive feedback from the SWL during the study period.
Participants will receive an education intervention delivered by a physiotherapist.
This intervention will take place preferentially at the participants' workplace at the end of the 2nd week post-randomization.
The session will last 30 to 45 minutes, and involve personalized, patient-centered education on their condition.
The physiotherapist will use open-ended questions to encourage participants to express their goals and address specific concerns related to their shoulder condition.
Given the expected diversity in physical constraints (manual vs. non-manual workers) and individual challenges, the session will be tailored to each worker needs.
At the end of the session, workers will receive a booklet summarizing key points, including: understanding shoulder anatomy, function and pain, managing shoulder pain, enhancing movement variability, adjusting work environment, and considering factors such as sleep, stress, coping mechanisms, and psychological factors on pain.
|
|
Active Comparator: Education
Education session at week 2.
|
Participants will receive an education intervention delivered by a physiotherapist.
This intervention will take place preferentially at the participants' workplace at the end of the 2nd week post-randomization.
The session will last 30 to 45 minutes, and involve personalized, patient-centered education on their condition.
The physiotherapist will use open-ended questions to encourage participants to express their goals and address specific concerns related to their shoulder condition.
Given the expected diversity in physical constraints (manual vs. non-manual workers) and individual challenges, the session will be tailored to each worker needs.
At the end of the session, workers will receive a booklet summarizing key points, including: understanding shoulder anatomy, function and pain, managing shoulder pain, enhancing movement variability, adjusting work environment, and considering factors such as sleep, stress, coping mechanisms, and psychological factors on pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility : quantitative component procedure
Time Frame: Baseline
|
Assessing trial recruitment success (Recruitment rate) : Track the rate of screened participants who consent to participate in the trial, using a screening and recruitment log.
|
Baseline
|
|
Feasibility : quantitative component procedure
Time Frame: From enrollment to the end of recruitment
|
Assessing trial recruitment success (Determining recruitment duration) : Evaluate the time required to recruit the target number of participants.
|
From enrollment to the end of recruitment
|
|
Feasibility : quantitative component procedure
Time Frame: From enrollment to the end the trial at 12 weeks
|
Assessing trial recruitment success (Retention rate) : Monitor the number of participants who complete the trial, and document reasons for attrition.
|
From enrollment to the end the trial at 12 weeks
|
|
Feasibility : quantitative component procedure
Time Frame: From enrollment to the end of the last completion questionnaire at 12 weeks
|
Completion rate : Report the completion rate for each questionnaire at each time point.
|
From enrollment to the end of the last completion questionnaire at 12 weeks
|
|
Feasibility : quantitative component procedure
Time Frame: From 2 weeks to 4 weeks of the intervention period
|
Evaluating adherence to the intervention : Self-reported SWL devise usage: Participants in the experimental group will complete a self-reported questionnaire at the end of each week during the 2-week intervention period to assess their adherence to using the SWL.
|
From 2 weeks to 4 weeks of the intervention period
|
|
Feasibility : qualitative component procedure
Time Frame: From 4 weeks to 12 weeks
|
Focus groups : All participants from the experimental group will be invited to participate to a focus group, to explore various aspects of feasibility such as the acceptability of the technology, the experience of wearing the SWL and receiving the feedback, and suggestion for potential improvement of the SWL.
|
From 4 weeks to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire-Work Module (QuickDASH-Work Module)
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
QuickDASH-Work Module includes 4 items, each scored from 1 to 5.
This scale range from 0 to 100, with 0 indicating the best function and 100 indicating the worst possible function
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire (QuickDASH)
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
The QuickDASH consists of 11 items, , each scored from 1 to 5.
This scale range from 0 to 100, with 0 indicating the best function and 100 indicating the worst possible function.
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Work Limitations Questionnaire (WLQ-25).
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
This 25-item questionnaire includes four subscales addressing four dimensions of job demands.
The total score ranges from 0 to 100, with 0 indicating no limitation and 100 indicating complete limitation
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Pain severity subscale of the Brief Pain Inventory Short Form (BPI-SF)
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
It includes 4 items measuring worst, least and average pain in the past 24 hours, as well as current pain, each scored on an 11-point numeric scale (0-10), where 0 indicates no pain and 10 represents the worst pain imaginable.
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Pain Self-Efficacy Questionnaire (PSEQ).
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
This questionnaire includes 10 items, each scored on a 7-point Likert scale (0 = not at all confident and 6 = completely confident).
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Western Ontario Rotator Cuff Index (WORC)
Time Frame: Baseline, 3 weeks, 6 weeks, 12 weeks
|
The WORC contains 21 items in total, each scored from 0 to 100, with 0 indicates best function and 100 indicating the worst possible function.
|
Baseline, 3 weeks, 6 weeks, 12 weeks
|
|
Physical work demands
Time Frame: At 1 week and 4 weeks
|
To evaluate physical work demands, workers in both groups will wear the SWL for three consecutive full working days during the 1st week (before the intervention for the experimental group).
Participants will log their physical work demands daily using the Ergowatchapp via a Mycap entry.
The following outcomes will be averaged for data analysis: 1) number of arm elevations (>60°) per day, 2) time spent with the arm elevated (>60°) per day.
|
At 1 week and 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Philippe Meidinger, PT, PhD student, PT, PhD student, Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS)
- Study Director: Jean-Sébastien Roy PT, PhD, Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2025
Primary Completion (Estimated)
March 1, 2026
Study Completion (Estimated)
July 1, 2026
Study Registration Dates
First Submitted
November 13, 2024
First Submitted That Met QC Criteria
November 14, 2024
First Posted (Actual)
November 18, 2024
Study Record Updates
Last Update Posted (Actual)
May 8, 2025
Last Update Submitted That Met QC Criteria
May 5, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP-13-2023-2784
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All IPD that underlie results in a publication (with anonymized data).
IPD Sharing Time Frame
All data will be available starting after 6 months after publication (with anonymized data).
IPD Sharing Access Criteria
For further information, please contact the authors
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Osteoarthritis
-
Indiana Hand to Shoulder CenterCTM BiomedicalActive, not recruitingShoulder Osteoarthritis | Osteoarthritis Shoulder | Glenohumeral OsteoarthritisUnited States
-
Poznan University of Medical SciencesRecruitingOsteoarthritis ShoulderPoland
-
Smith & Nephew, Inc.Recruiting
-
Lovisenberg Diakonale HospitalHaukeland University Hospital; Sykehuset Telemark; University Hospital, AkershusRecruitingShoulder Osteoarthritis | Arthroplasty, Replacement, ShoulderNorway
-
University Hospital, BrestRecruitingShoulder Osteoarthritis | Arthropathy ShoulderFrance
-
FX Shoulder SolutionsRecruitingOsteoarthritis Shoulder | Rotator Cuff Syndrome of Shoulder and Allied Disorders | Fracture, ShoulderUnited States
-
Icahn School of Medicine at Mount SinaiCompletedShoulder Osteoarthritis | Total Shoulder ArthroplastyUnited States
-
Northwestern UniversityWithdrawnShoulder Osteoarthritis | Arthropathy ShoulderUnited States
-
Zealand University HospitalHvidovre University HospitalActive, not recruitingShoulder Pain | Shoulder Osteoarthritis | Shoulder ArthritisDenmark
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
Clinical Trials on Shoulder watch load (SWL) feedback
-
Cairo UniversityRecruitingSubacromial Impingement SyndromeEgypt